EGFR and neoplasm: In addition, the tumor mutation distribution analysis showed that the EGFR mutation rate was slightly downregulated in the high GTMEIscore group, and the pathway enrichment analysis showed that proteins with upregulated levels of phosphorylation were significantly enriched in the EGFR tyrosine kinase inhibitor resistance pathway (Figure 5A).